Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ANEST IWATATSE:6381 +1.51%90 Peter Lynch Fair Value is 円1,625.11 as of Aug. 14, 2026, which is 100% below its 10-year median of 1.05. GuruFocus rates TSE:6381 with a GF Score™ of 90/100 and a GF Value™ of 円1,487.35 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 939 Industrial Products companies, ANEST IWATA ranks better than 61.13% on this metric.
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year. Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years. If 5-Year Growth Rate is greater than 25% a year, we use 25. If 5-Year Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Here, as of today, ANEST IWATA's PEG is 1. ANEST IWATA's 5-Year TTM EBITDA Growth Rate is 13.84.
ANEST IWATA's EPS without NRI for the trailing twelve months (TTM) ended in Mar. 2026 was 円117.42. Therefore, the Peter Lynch Fair Value for today is 円1,625.11.
As of today (2026-08-14), ANEST IWATA's share price is 円1955.00. ANEST IWATA's Peter Lynch fair value is 円1,625.11. Therefore, ANEST IWATA's Price to Peter Lynch Fair Value Ratio for today is 1.20.
The historical rank and industry rank for ANEST IWATA's Peter Lynch Fair Value or its related term are showing as below:
TSE:6381'
s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.75 Med: 1.05 Max: 2.51
Current: 1.2
During the past 13 years, the highest Price to Peter Lynch Fair Value Ratio of ANEST IWATA was 2.51. The lowest was 0.75. And the median was 1.05.
TSE:6381's Price-to-Peter-Lynch-Fair-Value is ranked better than 61.13% of 939
companies
in the Industrial Products industry
Industry Median: 1.51
vs TSE:6381: 1.20
Note: Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart.
ANEST IWATA (TSE:6381) Peter Lynch Fair Value Explanation
Peter Lynch Fair Value applies to growing companies. The ideal range for the growth rate is between 10 - 20% a year.
Peter Lynch thinks that the fair P/E value for a growth company equals its growth rate, that is PEG = 1. The earnings here is trailing twelve month (TTM) earnings. For non-bank companies, the growth rate we use is the average growth rate for EBITDA per share over the past 5 years. For Banks, the growth rate we use is the average growth rate for Book Value per share over the past 5 years.
Please don't confuse Peter Lynch Fair Value with the value reached in Peter Lynch Chart. In Peter Lynch chart, a fixed P/E ratio of 15 is used to draw the Earnings Line. Therefore the value reached has a P/E ratio of 15. But in Peter Lynch Fair Value calculation, P/E equals to the growth rate of EBITDA per share over the past 5 years, which is 13.84 instead of 15 in this case.
ANEST IWATA's Price to Peter Lynch Fair Value Ratio for today is calculated as
Price to Peter Lynch Fair Value
=
Share Price
/
Peter Lynch Fair Value
=
1955.00
/
1,625.11
=
1.20
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ANEST IWATA Peter Lynch Fair Value Related Terms
ANEST IWATA Peter Lynch Fair Value Historical Data
* Premium members only.
The historical data trend for ANEST IWATA's Peter Lynch Fair Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6381 vs GEV, ETN, PH: Peter Lynch Fair Value Comparison
For the Specialty Industrial Machinery subindustry, ANEST IWATA's Price-to-Peter-Lynch-Fair-Value, along with its competitors' market caps and Price-to-Peter-Lynch-Fair-Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ANEST IWATA Price-to-Peter-Lynch-Fair-Value vs Industrial Products Industry
For the Industrial Products industry and Industrials sector, ANEST IWATA's Price-to-Peter-Lynch-Fair-Value distribution charts can be found below:
* The bar in red indicates where ANEST IWATA's Price-to-Peter-Lynch-Fair-Value falls into.
ANEST IWATA's EPS without NRI for the trailing twelve months (TTM) uses the latest annual data, which was 円117.42.
* Note that for companies that do not have enough quarterly data to calculate the 5-Year TTM EBITDA Growth Rate, we use the annual data for the calculation.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Please be aware that the 5-Year TTM EBITDA Growth Rate is calculated based on TTM data over the last 5 years. For quarterly reported companies, the TTM data adds up the quarterly data reported by the company within the most recent 12 months. For companies that report semi-annually, annually, or do not have enough quarterly data, GuruFocus uses the annual data as the TTM data.
If 5-Year Earnings Growth Rate is greater than 25% a year, we use 25.
If 5-Year Earnings Growth Rate is smaller than 5% a year, we do not calculate Peter Lynch Fair Value.
Please note that we use the 5-year average growth rate of EBITDA per share as the growth rate for non-bank companies, as EBITDA growth is subject to less manipulations than net earnings per share. For banks, we use the 5-year average growth rate of Book Value per share as the growth rate. The reason is that EBITDA is not applicable to Banks and Book value is a relative important measurement for Banks. In the calculation, PEG=1 because Peter Lynch thinks that the fair P/E ratio of the growth stock is equal to its earnings growth rate.
What does a Peter Lynch Fair Value of 円1,625.11 mean?
ANEST IWATA (TSE:6381) has a Peter Lynch Fair Value of 円1,625.11 as of Aug. 14, 2026. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on ANEST IWATA and its competitors. This is 154672% above median its historical median of 1.05. Over the past decade, ANEST IWATA's Peter Lynch Fair Value has ranged from 0.75 to 2.51. According to the industry distribution chart, ANEST IWATA ranks #365 out of 939 companies in the Industrial Products industry, placing it in the top 38.9%.
Is ANEST IWATA's Peter Lynch Fair Value too high?
ANEST IWATA's current Peter Lynch Fair Value of 円1,625.11 is 154672% above median its 10-year median of 1.05. Over the past 10 years, this metric has ranged from a low of 0.75 to a high of 2.51. Based on the distribution chart, ANEST IWATA ranks #365 out of 939 companies in the Industrial Products industry, which is above the industry midpoint. Overall, ANEST IWATA has a GF Score™ of 90/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does ANEST IWATA's Peter Lynch Fair Value compare to GEV and ETN?
According to the Industrial Products industry distribution chart, ANEST IWATA ranks #365 out of 939 companies for Peter Lynch Fair Value. This puts ANEST IWATA in the upper half of its industry. The industry median Peter Lynch Fair Value is 1.51. Historically, ANEST IWATA's own Peter Lynch Fair Value has ranged from 0.75 to 2.51 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Peter Lynch Fair Value for an Industrial Products company?
The median Peter Lynch Fair Value among Industrial Products companies is 1.51, based on 939 companies in the industry. Companies in the top quartile (top 25%) have a Peter Lynch Fair Value significantly above this median, while those in the bottom quartile fall well below. However, Peter Lynch Fair Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Peter Lynch Fair Value mean?
A high Peter Lynch Fair Value can signal that a stock is expensive relative to its fundamentals. Peter Lynch Fair Value is the stock value based on a company's current earnings and five-year earnings growth, assuming a PEG of one. View historical data on ANEST IWATA and its competitors. For the Industrial Products industry, the median Peter Lynch Fair Value is 1.51 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. ANEST IWATA's current Peter Lynch Fair Value is 円1,625.11, which is 154672% above median its own 10-year median of 1.05. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ANEST IWATA stock overvalued right now?
Based on GuruFocus' analysis, ANEST IWATA (TSE:6381) is currently considered Significantly Overvalued. The stock's GF Value™ is 円1,487.35, compared to a current price of 円1,955.00 — trading 31.4% above its estimated fair value. The current Peter Lynch Fair Value is 円1,625.11, which is 154672% above median its 10-year median of 1.05. ANEST IWATA's overall GF Score™ is 90/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Peter Lynch Fair Value calculated?
Peter Lynch Fair Value is calculated from a company's financial statements. For ANEST IWATA (TSE:6381), the current Peter Lynch Fair Value is 円1,625.11 as of Aug. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is ANEST IWATA (TSE:6381) Overvalued in 2026?
Based on GuruFocus' analysis, ANEST IWATA stock appears to be overvalued.
The current stock price of 円1,955.00 is trading 31.4% above its estimated GF Value™ of 円1,487.35.
GuruFocus considers ANEST IWATA to be Significantly Overvalued.
Key valuation signals for TSE:6381:
Peter Lynch Fair Value: 円1,625.11 (154672% above median its 10-year median of 1.05)
GF Value™: 円1,487.35 vs. price of 円1,955.00 (31.4% above fair value)
No single metric tells the full story. See the TSE:6381 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
ANEST IWATA Corp manufactures and sells air compressors, pneumatic equipment and pneumatic tools. The company also manufactures and sells vacuum machinery, painting machinery, coating equipment, medical equipment, electric power supply equipment and power transmission equipment.
90GF Score
Get the complete analysis for TSE:6381
Peter Lynch Fair Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6381 has been successfully added to your 
